Moderna Reports Second Quarter 2026 Financial Results and Provides Business Updates
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Nasdaq reaches record high close, AI stocks rally
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
Moderna (MRNA) Tops Q2 EPS by 6c, Beats on Revenue
July 31, 2026 7:01 AM EDTModerna (NASDAQ: MRNA) reported Q2 EPS of ($1.97), $0.06 better than the analyst estimate of ($2.03). Revenue for the quarter came in at $100 million versus the consensus estimate of $99.91 million.
For earnings history and earnings-related data on Moderna (MRNA) click here.
... More